Skip to main content
21 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Venture Capital
Venture Capital
Forbion looks for emerging science
Read more
Build-to-buy model attracts Pharma investors
Read more
Health economics attracts venture investors
Read more
MorphoSys Innovation Capital: A venture fund with appetite for platforms
Read more
Atlas Venture & Index Ventures focus on startups
Read more
How Sweden's HealthCap expanded globally
Read more
New role for venture capital in pivotal trials
Read more
Sofinnova's Investment Strategy: Putting the entrepreneur first
Read more
A new venture capital model
Read more
Interview: 4-Antibody AG - How do you structure a biotech for divestment?
Read more
Pagination
Previous page
‹‹
Page 2
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form